Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications

Area of Science:

• Biochemistry
• Immunology
• Biotechnology

Background:

• Nanobodies are variable antigen-binding domains derived from heavy-chain-only antibodies found in Camelidae.
• They represent the smallest functional antigen-binding fragments, possessing a compact structure and low molecular weight compared to conventional antibodies.
• Their inherent stability and ease of modification make them attractive for various applications.

Purpose of the Study:

• To review recent advancements in the field of nanobodies.
• To focus on the versatile applications of nanobodies in biomedical research and practice.
• To highlight nanobodies as valuable biomolecules for future therapeutic and diagnostic innovations.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of studies focusing on nanobody development and application.
• Synthesis of information on nanobody characteristics and utility.

Main Results:

• Nanobodies exhibit exceptional stability and unique structural features.
• They have been successfully integrated into biomaterials.
• Applications span molecular recognition, tracing, drug delivery, molecular imaging, and therapeutics.

Conclusions:

• Nanobodies are highly versatile biomolecules with significant potential in biomedicine.
• Their unique properties facilitate diverse applications, from diagnostics to therapeutics.
• Continued research promises further expansion of nanobody utility in healthcare.